1-2 of 2
Andrew Kent
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment-free remission after ceasing venetoclax-based therapy in patients with acute myeloid leukemia

Chong Chyn Chua, Danielle Hammond, Andrew Kent, Ing Soo Tiong, Marina Y. Konopleva, Daniel A. Pollyea, Courtney D. DiNardo, Andrew H. Wei
Journal: Blood Advances
Blood Adv (2022) 6 (13): 3879–3883.
https://doi.org/10.1182/bloodadvances.2022007083
Published: 2022
Includes: Supplemental data
Journal Articles

Glasdegib as maintenance therapy for patients with AML and MDS patients at high risk for postallogeneic stem cell transplant relapse

Clinical Trials & Observations
Andrew Kent, Sumithira Vasu, Derek Schatz, Natalie Monson, Steven Devine, Clayton Smith, Jonathan A. Gutman, Daniel A. Pollyea
Journal: Blood Advances
Blood Adv (2020) 4 (13): 3102–3108.
https://doi.org/10.1182/bloodadvances.2020001991
Published: 2020
Includes: Supplemental data